http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2266388-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b6fd24bc72c6c02a2cd5a5655ae14f7d |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6849 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6901 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 |
| filingDate | 1997-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e47a0b169cd52bda79b261b2195500e0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e7e8e2e0cea1c0a9c0f9485c822b756 |
| publicationDate | 1998-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2266388-A1 |
| titleOfInvention | Polyethyleneglycol conjugated nanoerythrosomes, method of making same and use thereof |
| abstract | The present invention relates to nanoErythrosomes, a Drug Delivery System (DDS). More specifically, the present invention relates to a new method of production of nanoErythrosomes. Moreover, the present invention relates to nanoErythrosome compositions having a decreased immunogenic potential and to the use thereof in diagnostic and therapeutic methods. The invention further relates to the bioassays using the nanoErythrosome composition of the present invention to diagnose or prognose a predetermined condition in an animal, as well as kits containing those nanoErythrosomes compositions. |
| priorityDate | 1996-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 183.